Solence offers a personalized digital app to support women with Polycystic Ovary Syndrome (PCOS).
Solence has raised $1.9M in total funding. The most recent round was Seed. The last funding was announced in July 2025.
Solence's investors include Bpifrance, Impact Shakers, Celine Lazorthes, Stephane Mardel, Emmanuel Manceau.
Solence is headquartered in Paris, France.
Solence offers a personalized digital app to support women with Polycystic Ovary Syndrome (PCOS).
Solence is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Solence — Funding & Investors." VCBacked, July 10, 2025, https://www.vcbacked.co/company/solence. Accessed September 12, 2026.
VCBacked. (2025). Solence — Funding & Investors. Retrieved September 12, 2026, from https://www.vcbacked.co/company/solence
{{cite web |title=Solence — Funding & Investors |url=https://www.vcbacked.co/company/solence |website=VCBacked |access-date=September 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated